epidermal growth factor Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (6)
Any (7)

Phase 1 (1)
Phase 1/2 (3)
Phase 2 (2)
Phase 3 (2)
Unknown (5)

Interventional (10)
Observational (3)

Sun Yat-sen University (2)
BeiGene (1)
Beta Pharma (Suzhou) Co., Ltd. (1)
Fudan University (1)
H3 Biomedicine Inc. (1)
Herui Yao (1)
Kliniken Essen-Mitte (1)
Pierre Fabre Pharma GmbH (1)
Shenzhen Geno-Immune Medical Institute (1)
Universitaire Ziekenhuizen Leuven (1)
Virginia Commonwealth University (1)
Weill Medical College of Cornell University (1)

No (13)

No (13)

Adult (18+) (13)

I am/have/had

I am/have/hadplasma oestradiol

I am/have/hadsystemic therapy

I am/have/hadstereotactic body radiation therapy

I am/have/hadcore needle biopsy

I am/have/hadthromboplastin

I am/have/hadrecurrent disease

I am/have/hadgastric cancer

I am/have/hadrenal function test

I am/have/hadchemoradiotherapy

I am/have/hadneutrophil count

I am/have/hadmaintenance therapy

I am/have/hadmetastatic adenocarcinoma

I am/have/haddrug test

I am/have/hadher2-negative breast cancer

I am/have/hadcancer chemotherapy

I am/have/hadestrogen

I am/have/haddrug evaluation

I am/have/hadadjuvant therapy

I am/have/hadoophorectomy

I am/have/hadepidermal growth factor receptor

added new label for I am/have/had

I am looking for

I am looking forerbb2

I am looking forcisplatin

I am looking forconjugated bilirubin

I am looking fortrastuzumab

I am looking forgrowth factor

I am looking forpalbociclib

I am looking fordocetaxel

I am looking forneratinib

I am looking forpertuzumab

I am looking forhormone therapy

I am looking forblockade

I am looking forestradiol

I am looking forchromogenic in situ hybridization

I am looking forletrozole

I am looking forendocrine therapy

I am looking fortamoxifen

I am looking forfulvestrant

I am looking forcish

I am looking forestrogen

I am looking forbispecific antibody

added new label for I am looking for

Advanced Filters

Found 13 clinical trials

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Recruiting

LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

To determine whether in patients with EGFR mutated advanced NSCLC and osimertinib as first-line treatment, the (repeated) use of LAT to 3 OP lesions and continuation of first-line osimertinib, improves the median progression-free survival by more than 3 months (i.e. PFS2-PFS1 = >3 months).

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 100s
Observational Study
For Females
Family Medicine
Recruiting

Real-life Pan-HER-blockade With Neratinib

So far, there is no data available on treatment of patients with early-stage hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-overexpressed/amplified breast cancer, who completed adjuvant trastuzumab-based therapy less than one year ago, in the clinical routine setting.

erbb2

epidermal growth factor receptor

immunostimulant

epidermal growth factor

breast cancer stage

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 100s
Observational Study
For Females
Recruiting

Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy

Neoadjuvant systemic therapy (NST) is increasingly recommended for patients with early breast cancer, and the rate of patients with pathological complete remission (pCR) is increasing due to the use of modern chemotherapy regimens and targeted therapies, especially in patients with human epidermal growth factor receptor 2 positive (HER2+) breast cancer …

0 views
19 Feb, 2024